Literature DB >> 15858395

Calcium channel blockers: a more expansive treatment role.

Domenic A Sica1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15858395      PMCID： PMC8109595          DOI： 10.1111/j.1524-6175.2006.04495.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  21 in total

1.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

Authors:  E J Lewis; L G Hunsicker; W R Clarke; T Berl; M A Pohl; J B Lewis; E Ritz; R C Atkins; R Rohde; I Raz
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

2.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

3.  Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.

Authors:  Steven E Nissen; E Murat Tuzcu; Peter Libby; Paul D Thompson; Magdi Ghali; Dahlia Garza; Lance Berman; Harry Shi; Ethel Buebendorf; Eric J Topol
Journal:  JAMA       Date:  2004-11-10       Impact factor: 56.272

Review 4.  Systematic review: antihypertensive drug therapy in black patients.

Authors:  Lizzy M Brewster; Gert A van Montfrans; Jos Kleijnen
Journal:  Ann Intern Med       Date:  2004-10-19       Impact factor: 25.391

Review 5.  Calcium antagonists.

Authors:  Ehud Grossman; Franz H Messerli
Journal:  Prog Cardiovasc Dis       Date:  2004 Jul-Aug       Impact factor: 8.194

Review 6.  Systolic hypertension in older persons.

Authors:  Sarwat I Chaudhry; Harlan M Krumholz; JoAnne Micale Foody
Journal:  JAMA       Date:  2004-09-01       Impact factor: 56.272

7.  Reserpine and breast cancer. A community-based longitudinal study of 2,000 hypertensive women.

Authors:  D R Labarthe; W M O'Fallon
Journal:  JAMA       Date:  1980-06-13       Impact factor: 56.272

8.  Factors influencing the hypotensive effects of calcium antagonists.

Authors:  P Erne; P Bolli; O Bertel; U L Hulthen; W Kiowski; F B Muller; F Buhler
Journal:  Hypertension       Date:  1983 Jul-Aug       Impact factor: 10.190

9.  Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.

Authors: 
Journal:  Am J Cardiol       Date:  1985-01-01       Impact factor: 2.778

Review 10.  Comparative pharmacology of calcium antagonists.

Authors:  T W Wilson; D W Quest
Journal:  Can J Cardiol       Date:  1995-03       Impact factor: 5.223
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.